Saturn V Capital Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Saturn V Capital Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-52,781	Closed	-$752K	–	28
2023 Q4	$752K	Buy	+52,781	New	+$600K	0.29%	23

Saturn V Capital Management's AMAM Position: Q1 2024 in Review

Saturn V Capital Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 52,781 shares — an estimated $752K sold.

Saturn V Capital Management first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $752K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Saturn V Capital Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Saturn V Capital Management sold 52,781 Ambrx Biopharma Inc shares in Q1 2024, an estimated $752K.
Saturn V Capital Management first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Saturn V Capital Management's Ambrx Biopharma Inc position peaked at $752K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Saturn V Capital Management's 13F filing for Q1 2024, filed 15 May 2024.